Outline. Genomics Medicine: Managing your own health. - Market overview: now and future. - What is genomic medicine?
|
|
- Clinton Lynch
- 5 years ago
- Views:
Transcription
1 Genomics Medicine: Managing your own health Mostafa Ronaghi SVP & CTO, Illumina Barcelona June Illumina, Inc. All rights reserved. Illumina, illuminadx, BaseSpace, BeadArray, BeadXpress, cbot, CSPro, DASL, DesignStudio, Eco, GAIIx, Genetic Energy, Genome Analyzer, GenomeStudio, GoldenGate, HiScan, HiSeq, Infinium, iselect, MiSeq, Nextera, Sentrix, SeqMonitor, Solexa, TruSeq, VeraCode, the pumpkin orange color, and the Genetic Energy streaming bases design are trademarks or registered trademarks of Illumina, Inc. All other brands and names contained herein are the property of their respective owners. PN Outline - Market overview: now and future - What is genomic medicine? - How is genomic medicine being implemented? - A personal story - Potential opportunities 2 1
2 The science of GENOMICS is at the beginning of a NEW era of innovation 3 Explosion in amounts of genetic data 4 2
3 McKinsey Report on Disruptive Technologies The potential economic impact of next-generation gene sequencing in the applications that we have sized in health care, agriculture, and the production of substances such as biofuels could be $700 billion to $1.6 trillion a year by 2025 ~80% of this potential value would be realized through Genomic Medicine 5 How much does it cost to sequence a genome? 2006 $ 10 Million Cost/Genome (30X coverage) 2007 $ 1 Million 2008 $ 100 K 2009 $ 20 K 2010 $ 10K 2013 $
4 Sequencing Cost Reduction Out Pacing Moore s Law 100,000 10,000 Moore s law 1, Sequencing cost Cost of sequencing a genome could drop to ~$100 within the next decade 8 4
5 What is accelerating this cost reduction? 9 Genomic Medicine: potential drivers Drivers: Rise in global population Aged population Rise in cost of healthcare 10 5
6 MegaTrends Population is increasing at a decreasing rate 11 MegaTrends The developed world continues to age 15% of population will be over 60 years old by
7 MegaTrends Healthcare is different PC Cost CT Scan 32% $ % $ $ $ Altair 8800 Apple imac GS 13 MegaTrends US Healthcare spending is inefficient Here s one reason 14 7
8 Economical impact: $700 billion to $1.6 trillion per year in 2025 McKinsey s report Estimated scope in 2025 Estimated potential reach in 2025 Potential value gain Estimated deaths from relevant diseases - Cancer: 12 million - Cardiovascular: 23 million - Type II Diabetes: 4 million Potential with access to relevant treatment - Cancer: 20-40% - Cardiovascular: 15-40% - Type II Diabetes: 20-40% Expected life expectancy - Cancer: 20-40% - Cardiovascular: 15-40% - Type II Diabetes: 20-40% 160 million Newborns Access to potential genetic screening - Developed world: 100% - Less-developed world: 30-50% Value of potential screening - Developed world: $ Less-developed world $ We have to reduce the cost of health care? Otherwise we will go broke 16 8
9 Outline - Market overview: now and future - What is genomic medicine? - How is genomic medicine being implemented? - A personal story - Potential opportunities 17 What is Genomic Medicine? Is based on understanding the impact of our entire genome and environmental factors on disease and health Emerging as an important part of: Diagnostics Prognostics Risk factor management Treatment in clinical practice 18 9
10 How do we sequence a genome? ~40 trillion cells in human body A genome consists of 6.4 billion nucleotides (3.2 B from each parent) Genome is chopped to tens of millions fragments All fragments are then sequenced (~30X coverage) All fragments are assembled to construct a genome 19 A journey towards finishing the first human genome 20 10
11 Completion of the first Human genome in Gene testing has demonstrated cost saving 22 11
12 PKU Screening All published studies show that PKU screening and treatment represent a net direct cost savings to society Phenylketonuria: Screening and Management NIH Consensus Statement Online Multigene Assay Predicts Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer Gene expression analysis was combined with an algorithm for calculating risk for distant recurrence of breast cancer % confidence interval curves Recurrence score for individual patients Source: Paik, et al., N Engl J Med, December
13 25 Why do we need to sequence whole Genome? 26 13
14 Single gene testing not comprehensive enough for complex diseases 2009 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense Out of Life, Oligator, Sentrix, GoldenGate, GoldenGate Indexing, DASL, BeadArray, Array of Arrays, Infinium, BeadXpress, VeraCode, IntelliHyb, iselect, CSPro, and GenomeStudio are registered trademarks or trademarks of Illumina, Inc. All other brands and names contained herein are the property of their respective owners. Full Genome sequence may turn on all lights 2009 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense Out of Life, Oligator, Sentrix, GoldenGate, GoldenGate Indexing, DASL, BeadArray, Array of Arrays, Infinium, BeadXpress, VeraCode, IntelliHyb, iselect, CSPro, and GenomeStudio are registered trademarks or trademarks of Illumina, Inc. All other brands and names contained herein are the property of their respective owners. 14
15 Outline - Market overview: now and future - What is genomic medicine? - How is genomic medicine being implemented? - A personal story - Potential opportunities 29 Cancer diagnostics Determine if a patient is a carrier of the BRCA1 or BRCA2 gene mutations provide individualized information on response to certain types of therapy provide individualized information on response to certain types of therapy provide individualized information on response to certain types of therapy using a gene-panel Provides information that associates biomarker status to agents with potential clinical benefit or potential lack of clinical benefit
16 Cancer care management Immuno Repertoire Sequencing Enables physicians to utilize sequencing-based minimal residual disease (MRD) detection as a clinical decision-making tool Faster, More accurate, Cheaper, Safer and more pleasant to the patients when compared to CT-scan 31 Carrier Screening Babies with genetic disease are often born to healthy parents A comprehensive test for 100+ genetic diseases Screens for more than 20 genetic disorders Screens for more than 600 genetic disorders Also provide full genome sequencing 32 16
17 Prenatal testing A next-generation sequencing prenatal test Has replaced more than 50% of Amniocentesis test Faster, More accurate, Cheaper, Safer and more pleasant to the patients when compared to amniocentesis test 33 Genomics in Wellness Genophen develops, translates and integrates the latest developments in healthcare and genomics to help you guide decisions about your health 34 A Holistic view of human health 17
18 Outline - Market overview: now and future - What is genomic medicine? - How is genomic medicine being implemented? - A personal story - Potential opportunities 35 Bone fracture Patient A Have had 11 fractures Bone density: 20% below average population 36 18
19 Bone fracture 37 My Genome Ships blood Sends raw data Trained MD in genetics Interpret genome data Make recommendation to patient Performs genome sequencing in their CLIA lab Discovered: Vitamin D uptake low (Fok1 gene) lower bone density 1000 mg/day in the last four months did increase the bone density 38 19
20 Heart attack - Mother died from heart attack at the age of 47 - Cholesterol on the boarder line - 3 years of diet and exercise did not help - Doctor recommended statin 10 mg/day - After 3 years recommended 20 mg/day - Sign of muscle pain appeared 39 My Genome Statin: different efficiency on different population Decreased sensitivity for Simvastatin (Zocor) increased sensitivity for Rosuvastatin (Crestor) Action: Replaced Zocor by Crestor and reduced the dosage by 4 folds My Cholesterol is lower than before and no more side effect Using Genophen for further investigation 40 20
21 Outline - Market overview: now and future - What is genomic medicine? - How is genomic medicine being implemented? - A personal story - Potential opportunities 41 Genomics: Barriers and Enablers Enablers - ~7000 disease genes discovered so far - Fast and cheap sequencing will enable discovery of these genes Barriers - There is still much that scientists do not understand about genomics - Ownership of data could be an issue - Interpretation of genome is still challenging - GMO food regulation needs to be defined 42 21
22 Sequencing Alters the Landscape A Few Predictions Consumer Agriculture Cancer BioPharm Genetics Forensics Infectious Disease Research Human Health Reproductive Health 43 Sequencing Alters the Landscape A Few Predictions Time Frame (years) Sequencing begins to directly save lives Radical acceleration in rate of genomic discovery/insights Tumor samples routinely sequenced and become Standard of Care Nations begin sequencing their populations Complete human sequence under $1000 Consumer Agriculture Cancer Infants routinely sequenced at birth BioPharm Genetics Cancer succumbs to new technology tools Forensics Infectious Disease Research Human Health Reproductive Health 44 22
23 Sequencing Alters the Landscape A few market oppotunities Agricultur e BioPha rm Consu mer Canc er Gen etics Forensic s Research Human Health Infec tious Dise ase Reproduc tive Health Consumer: ancestry, vitamin dosage personalization, match making Diagnostics: cancer, diabetes, cardiovascular, and a lot more Agriculture: high value chemicals, biofuel, Animal food and GMO for efficiency 45 Gene modified food McKinsey s report The total area planted in GM crops has risen from 1.7 million hectares in 1996 to more than 170 million hectares in 2012, and for the first time farmers in developing economies planted more hectares of GM crops than did farmers in advanced countries. Gene Modified Food will become the dominant food type in the stores - safer than pesticide treated food - cheaper 46 23
24 the sequence of the human DNA is the reality of the species, and everything that happens in the world depends upon those sequences. Renato Dulbecco, Nobel Laureate 47 Thank You 48 24
Genomic Information Revolution(s)
Genomic Information Revolution(s) Scott D. Kahn, PhD Chief Information Officer 18 September 2013 2013 Illumina, Inc. All rights reserved. Illumina, IlluminaDx, BaseSpace, BeadArray, BeadXpress, cbot, CSPro,
More informationIntroduction to the MiSeq
Introduction to the MiSeq 2011 Illumina, Inc. All rights reserved. Illumina, illuminadx, BeadArray, BeadXpress, cbot, CSPro, DASL, Eco, Genetic Energy, GAIIx, Genome Analyzer, GenomeStudio, GoldenGate,
More informationGetting high-quality cytogenetic data is a SNP.
Getting high-quality cytogenetic data is a SNP. SNP data. Increased insight. Cytogenetics is at the forefront of the study of cancer and congenital disorders. And we put you at the forefront of cytogenetics.
More informationEnabling New Markets for Growth Empowering the Genomics Revolution
Enabling New Markets for Growth Empowering the Genomics Revolution Peter Fromen Sr. Director, Product Marketing & Market Development 2013 NGS User Forum Tokyo, Japan June 27, 2013 2013 Illumina, Inc. All
More informationIllumina Sequencing Overview
Illumina Sequencing Overview Part # 15045845_Rev.C 2013 Illumina, Inc. All rights reserved. Illumina, IlluminaDx, BaseSpace, BeadArray, BeadXpress, cbot, CSPro, DASL, DesignStudio, Eco, GAIIx, Genetic
More informationMiSeq. system applications
MiSeq system applications Choose your application. Load, and go. Focused power. Speed and simplicity for targeted and small-genome sequencing. Optimized sample preparation kits, push-button sequencing,
More informationTransforming Services in the World of Life Sciences
Transforming Services in the World of Life Sciences Kirk Malloy Vice President Global Customer Solutions Illumina, Inc. 2010 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense
More informationWebinar 1: Understanding Reimbursement Implications For 2013
Webinar 1: Understanding Reimbursement Implications For 2013 A Molecular Pathology Coding and Reimbursement Webinar Series in partnership with Quorum Consulting February 12, 2013 2013 Illumina, Inc. All
More informationGenome Analyzer. RNA ChIP
Genome Analyzer 2009 11 26 2009 Illumina Inc All rights reserved 2009 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense Out of Life, Oligator, Sentrix, GoldenGate, GoldenGate
More informationIllumina s Suite of Targeted Resequencing Solutions
Illumina s Suite of Targeted Resequencing Solutions Colin Baron Sr. Product Manager Sequencing Applications 2011 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense Out of Life,
More informationIllumina Diagnostics. Emily Winn-Deen, PhD Vice President, Product Development Diagnostics
Introduction ti to Illumina Diagnostics Emily Winn-Deen, PhD Vice President, Product Development Diagnostics 2010 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense Out of Life,
More informationStrategies for Integrating MES with other Enterprise Systems, Equipment and Controllers
Strategies for Integrating MES with other Enterprise Systems, Equipment and Controllers S. Willcott Solution Architect, Operations Informatics 2013 Illumina, Inc. All rights reserved. Illumina, IlluminaDx,
More informationRevolutionizing genetics in the cattle industry. Extensive toolset. Proven technology. Collaborative approach.
Revolutionizing genetics in the cattle industry. Extensive toolset. Proven technology. Collaborative approach. Breed success. Join the revolution. Beef cattle with improved meat quality. Exceptional tenderness.
More informationEpiGnome Methyl-Seq - DNA Methylation Analysis using Whole Genome Bisulfite Sequencing
EpiGnome Methyl-Seq - DNA Methylation Analysis using Whole Genome Bisulfite Sequencing Victor Ruotti! Bioinformatics Scientist! Epicentre (An Illumina company) 2013 Illumina, Inc. All rights reserved.
More informationThe Expanded Illumina Sequencing Portfolio New Sample Prep Solutions and Workflow
The Expanded Illumina Sequencing Portfolio New Sample Prep Solutions and Workflow Marcus Hausch, Ph.D. 2010 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense Out of Life, Oligator,
More informationIndustrial Hygiene in the Genomics Revolution Keith Rego, MS, CSP, CIH Sr. Manager, IH and Chemical Compliance
Industrial Hygiene in the Genomics Revolution Keith Rego, MS, CSP, CIH Sr. Manager, IH and Chemical Compliance 2015 CIHC San Francisco, CA 2015 Illumina, Inc. All rights reserved. Illumina, 24sure, BaseSpace,
More informationAttracting and Engaging Talent in Mid-Market Organizations
Attracting and Engaging Talent in Mid-Market Organizations April 27, 2016 Denise Moulton Research Manager, Bersin by Deloitte, Deloitte Consulting LLP Celia Harper-Guerra Global Head of Talent Acquisition,
More informationIllumina Custom Capabilities: Amplicons, Enrichment and iselect
Illumina Custom Capabilities: Amplicons, Enrichment and iselect Daniel Peiffer, PhD Sr. Product Manager DNA Sequencing Applications Tuesday, March 22, 2011 2010 Illumina, Inc. All rights reserved. Illumina,
More informationIllumina Microarray Solutions. A complete range of microarrays for every need.
Illumina Microarray Solutions. A complete range of microarrays for every need. 5742716013 It just keeps getting A history of progress. A future of promise. For all applications. For all needs. Illumina
More informationBenefits to validating GWAS studies with custom genotyping
Benefits to validating GWAS studies with custom genotyping Daniel Peiffer, PhD Sr. Product Manager Genotyping Applications 2010 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making
More information2010 LETTER TO SHAREHOLDERS. Redefining the trajectory of sequencing.
2010 LETTER TO SHAREHOLDERS Redefining the trajectory of sequencing. Dear Fellow Shareholders: 2010 was a transformational year for Illumina. We launched the company s most successful product to date,
More informationRoadmap: genotyping studies in the post-1kgp era. Alex Helm Product Manager Genotyping Applications
Illumina s GWAS Roadmap: next-generation genotyping studies in the post-1kgp era Alex Helm Product Manager Genotyping Applications 2010 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa,
More informationSingle Cell Washing and Handling. Introduction 1 Preparation 3 Cell Wash Protocol 5 Technical Assistance 7
Single Cell Washing and Handling Introduction 1 Preparation 3 Cell Wash Protocol 5 Technical Assistance 7 ILLUMINA PROPRIETARY Part # 15056987 Rev. A July 2014 This document and its contents are proprietary
More informationwww.illumina.com/hiseq www.illumina.com FOR RESEARCH USE ONLY 2012 2014 Illumina, Inc. All rights reserved. Illumina, BaseSpace, cbot, CSPro, Genetic Energy, HiSeq, Nextera, TruSeq, the pumpkin orange
More informationNext-Generation Sequencing: custom solutions
Next-Generation Sequencing: custom solutions Julien Abriol & Olivier Lucas, Ph.D. Territory Account Manager Inside Sales Consultant. 2011 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa,
More informationIllumina s GWAS Roadmap: next-generation genotyping studies in the post-1kgp era
Illumina s GWAS Roadmap: next-generation genotyping studies in the post-1kgp era Anthony Green Sr. Genotyping Sales Specialist North America 2010 Illumina, Inc. All rights reserved. Illumina, illuminadx,
More informationTotal genomic solutions for biobanks. Maximizing the value of your specimens.
Total genomic solutions for biobanks. Maximizing the value of your specimens. Unlock the true potential of your biological samples. Greater understanding. Increased value. Value-driven biobanking. Now
More informationIllumina Technology Updates
Illumina Technology Updates Michael G Smith Genomics Specialist June 1, 2011 2011 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense Out of Life, Oligator, Sentrix, GoldenGate,
More informationIntroduction to the NextSeq System
Introduction to the NextSeq System 2015 Illumina, Inc. All rights reserved. Illumina, 24sure, BaseSpace, BeadArray, BlueFish, BlueFuse, BlueGnome, cbot, CSPro, CytoChip, DesignStudio, Epicentre, ForenSeq,
More informationHiSeq Rapid Primer Rehybridization Reference Guide
HiSeq Rapid Primer Rehybridization Reference Guide FOR RESEARCH USE ONLY Revision History 3 Introduction 4 Rapid Rehyb Kits Overview 5 Prepare Rehyb Reagents 6 Manually Prime Reagents 7 Set Up a Rehyb
More informationillumina Nanotechnology for a Genomic Revolution
illumina Nanotechnology for a Genomic Revolution Shane Bowen, PhD Director, Scientific Research Department of Research and Technology Development International MicroNano Conference Amsterdam, December
More informationE2ES to Accelerate Next-Generation Genome Analysis in Clinical Research
www.hcltech.com E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research whitepaper April 2015 TABLE OF CONTENTS Introduction 3 Challenges associated with NGS data analysis 3 HCL s NGS Solution
More informationGenomics: A Paradigm Shift in Animal Breeding
FAO/ICAR African Symposium Pretoria, April 14-17, 2015 Genomics: A Paradigm Shift in Animal Breeding André Eggen, PhD Market Development Manager Agrigenomics, illumina 2014 Illumina, Inc. All rights reserved.
More informationTruSight HLA Sequencing Panel Protocol Guide
TruSight HLA Sequencing Panel Protocol Guide For Research Use Only. Not for use in diagnostic procedures. Generate HLA PCR Amplicons 3 Clean Up HLA PCR Amplicons 5 Normalize HLA PCR Amplicons 6 Tagment
More informationTruSeq DNA PCR-Free Library Prep Protocol Guide
TruSeq DNA PCR-Free Library Prep Protocol Guide For Research Use Only. Not for use in diagnostic procedures. Fragment DNA 3 Repair Ends and Select Library Size 5 Adenylate 3ʹ Ends 7 Ligate Adapters 8 Validate
More informationWhat is Precision Medicine?
Precision Medicine Precision Medicine describes the delivery of the right treatment to the right person at the right time. It has the power to improve health outcomes by using technology and data to tailor
More informationTruSeq Nano DNA Library Prep Protocol Guide
TruSeq Nano DNA Library Prep Protocol Guide For Research Use Only. Not for use in diagnostic procedures. Fragment DNA 3 Repair Ends and Select Library Size 5 Adenylate 3ʹ Ends 7 Ligate Adapters 8 Enrich
More informationTestimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association
Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association Before the House Energy and Commerce Subcommittee on Health 21st Century Cures: Examining the Regulation of Laboratory
More informationqpcr Quantification Guide
qpcr Quantification Guide FOR RESEARCH USE ONLY Introduction 3 Consumables and Equipment 5 Select Control Template 7 Dilute qpcr Control Template 8 Dilute Libraries 9 Prepare Reaction Mix 10 Aliquot to
More informationThe BeadXpress System: An Array of Applications for the Molecular Lab
The BeadXpress System: An Array of Applications for the Molecular Lab Gianluca Roma Product Manager 29 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense Out of Life, Oligator,
More information23andMe Personal Genome Service (PGS) Genetic Health Risk Report Package Insert BRCA1/BRCA2 (Selected Variants)
23andMe Personal Genome Service (PGS) Genetic Health Risk Report Package Insert /BRCA2 (Selected Variants) Table of contents Indications for use Summary and explanation of the test Important considerations
More informationTruSight Cardio Sequencing Kit Protocol Guide
TruSight Cardio Sequencing Kit Protocol Guide For Research Use Only. Not for use in diagnostic procedures. Tagment Genomic DNA 3 Clean Up Tagmented DNA 4 Amplify Tagmented DNA 5 Clean Up Amplified DNA
More informationData Analysis with CASAVA v1.8 and the MiSeq Reporter
Data Analysis with CASAVA v1.8 and the MiSeq Reporter Eric Smith, PhD Bioinformatics Scientist September 15 th, 2011 2010 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense
More informationHuman Genomics, Precision Medicine, and Advancing Human Health. The Human Genome. The Origin of Genomics : 1987
Human Genomics, Precision Medicine, and Advancing Human Health Eric Green, M.D., Ph.D. Director, NHGRI The Human Genome Cells Nucleus Chromosome DNA Human Genome: 3 Billion Bases (letters) The Origin of
More informationTowards a P4 Healthcare System: Predictive, Preventive, Personalized & Participatory
Towards a P4 Healthcare System: Predictive, Preventive, Personalized & Participatory Bull, 2012 Natalia Jiménez Lozano Business Development Manager BULL e-health Consultancy & Business Solutions Tlf: 913939253
More informationGenetically Sequencing Healthy Babies Yielded Surprising Results
Genetically Sequencing Healthy Babies Yielded Surprising Results FUTURE FRONTIERS OPINION ESSAY Robert C. Green, MD, MPH January 22, 2019 8 MINUTE READ A newborn and mother in the hospital - first touch.
More information"Expanded applications for NGS library prep exploring rapid workflows with Nextera and challenging RNA samples"
"Expanded applications for NGS library prep exploring rapid workflows with Nextera and challenging RNA samples" Todd Deppe Sample Prep Specialist Regional Marketing UCR Feb 11, 2014 2013 Illumina, Inc.
More informationAGRO/ANSC/BIO/GENE/HORT 305 Fall, 2016 Overview of Genetics Lecture outline (Chpt 1, Genetics by Brooker) #1
AGRO/ANSC/BIO/GENE/HORT 305 Fall, 2016 Overview of Genetics Lecture outline (Chpt 1, Genetics by Brooker) #1 - Genetics: Progress from Mendel to DNA: Gregor Mendel, in the mid 19 th century provided the
More informationGenomes contain all of the information needed for an organism to grow and survive.
Section 3: Genomes contain all of the information needed for an organism to grow and survive. K What I Know W What I Want to Find Out L What I Learned Essential Questions What are the components of the
More informationPresented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego
Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Discuss the difference between DNA Genotyping and Genome Sequencing What makes you who you
More informationWritten Response #17: Are Genetically Modified Foods Safe?
DNA Technology Written Response #17: Are Genetically Modified Foods Safe? Decide if you think GMO foods are safe. You will need to write whether you think they are safe or not and include 3 reasons for
More informationVisit our Career Flowchart to get more information on some of these career paths.
Visit our Career Flowchart to get more information on some of these career paths. Academic Research Faculty: This career path consists of university or college professors who conduct research. They select
More informationIntegrating Genomics in Family Medicine
Lehigh Valley Health Network LVHN Scholarly Works Department of Family Medicine Integrating Genomics in Family Medicine Brian Stello MD Lehigh Valley Health Network, Brian.Stello@lvhn.org Follow this and
More informationYOUR FIRST CHOICE FOR IN-OFFICE GENETIC TESTING
YOUR FIRST CHOICE FOR IN-OFFICE GENETIC TESTING THE NEW STANDARD OF CARE WHY GENETIC TESTING? Genetic testing makes it possible to know a priori how your patients will metabolize a specific drug. It is
More informationMGI: The power of AI and genetic sequencing
MGI: The power of AI and genetic sequencing The illnesses a person experiences in their lifetime are to a large extent determined by genetics. But today, the predictive power of gene sequencing technology
More informationChapter 5 Learning Objectives
Schedule and Announcements Go over Exam 1 Look at Elodea (plant cells) Start Chapter 5 Quiz Thursday over lab material Science Café 2 Friday Don t forget- research plan for project is due Friday September
More informationUS Food and Drug Administration. Sandra L. Kweder, MD Deputy Director, Europe Office
US Food and Drug Administration Sandra L. Kweder, MD Deputy Director, Europe Office Basics Disclaimer The views in this presentation are my own I have no commercial involvement in any of these activities
More informationA Technical Guide to Aneuploidy Calling with VeriSeq PGS
A Technical Guide to Aneuploidy Calling with VeriSeq PGS Introduction 3 Typical Cases 4 Examples of Calling Challenging Profiles 7 Mosaic Samples 10 Segmental Copy Number Changes 11 Differences Between
More informationWhole Genome Sequencing in Cancer Diagnostics (research) Nederlandse Pathologiedagen 19 & 20 November 2015
Whole Genome Sequencing in Cancer Diagnostics (research) Nederlandse Pathologiedagen 19 & 20 November 2015 Dr. I.J. Nijman Disclosure slide (Potential) conflict of interest None For this meeting relevant
More informationThe MiniSeq System. Explore the possibilities. Discover demonstrated NGS workflows for molecular biology applications.
The MiniSeq System. Explore the possibilities. Discover demonstrated NGS workflows for molecular biology applications. Let your work flow with Illumina NGS. The MiniSeq System delivers powerful and cost-effective
More informationUnit 3.notebook June 03, Genetic Counseling. May 11 12:18 PM. Genetic Counseling
Genetic Counseling Until recently, it was very difficult to determine the health of an unborn baby. Today, with new research and technology, information can be gathered during: > fetal development > before
More informationHigh-throughput scale. Desktop simplicity.
High-throughput scale. Desktop simplicity. NextSeq 500 System. Flexible power. Speed and simplicity for whole-genome, exome, and transcriptome sequencing. Harness the power of next-generation sequencing.
More informationInformed Consent for Columbia Combined Genetic Panel (CCGP) for Adults Please read the following
Informed Consent for Columbia Combined Genetic Panel (CCGP) for Adults Please read the following form carefully and discuss with your ordering physician/genetic counselor before signing consent. 1. The
More informationA New Era of Clinical Diagnostics: How the Business Model is Changing.
A New Era of Clinical Diagnostics: How the Business Model is Changing. Nancy J Kelley, President and CEO of Nancy J Kelley & Associates Remarks to BTIG Emerging Technologies in Healthcare Diagnostics September
More informationTruSeq Enrichment Guide FOR RESEARCH USE ONLY
TruSeq Enrichment Guide FOR RESEARCH USE ONLY ILLUMINA PROPRIETARY Catalog # FC-930-1012 Part # 15013230 Rev. E June 2011 TruSeq Enrichment Guide ii Notice Notice This document and its contents are proprietary
More informationPersonal Genomics Platform White Paper Last Updated November 15, Executive Summary
Executive Summary Helix is a personal genomics platform company with a simple but powerful mission: to empower every person to improve their life through DNA. Our platform includes saliva sample collection,
More informationGenomic solutions for complex disease
Genomic solutions for complex disease Power your with our genomic solutions Access a breadth of applications. Gain a depth of insights. To enhance their understanding of complex disease, researchers are
More informationWhat can a patient s DNA tell health care providers. Dr. Catalina Lopez-Correa CSO & VP Sector Development at Genome British Columbia
What can a patient s DNA tell health care providers Dr. Catalina Lopez-Correa CSO & VP Sector Development at Genome British Columbia President s Speakers Series Alberta Health Services (AHS) November 21st,
More informationPLTW Biomedical Science Medical Interventions Course Outline
Follow the fictitious Smith family as you learn about the prevention, diagnosis, and treatment of disease. Play the role of biomedical professionals to analyze case information and diagnose and treat your
More informationMolecular Diagnostics
Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R
More informationIntroduction to Bioinformatics
Introduction to Bioinformatics Richard Corbett Canada s Michael Smith Genome Sciences Centre Vancouver, British Columbia June 28, 2017 Our mandate is to advance knowledge about cancer and other diseases
More informationMAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE
MAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE THE RESEARCH WE DO TODAY WILL DETERMINE THE TYPE OF MEDICAL AND SURGICAL PRACTICE WE CARRY ON AT THE CLINIC
More informationIllumina Bio-Rad Single Cell Sequencing For Research Use Only. Not for use in diagnostic procedures.
Illumina Bio-Rad Single Cell Sequencing 2016 Illumina, Inc. All rights reserved. Illumina, 24sure, BaseSpace, BeadArray, BlueFish, BlueFuse, BlueGnome, cbot, CSPro, CytoChip, DesignStudio, Epicentre, ForenSeq,
More informationTowards Personalized Medicine: Leveraging Patient Similarity and Drug Similarity Analytics
Towards Personalized Medicine: Leveraging Patient Similarity and Drug Similarity Analytics Ping Zhang, Fei Wang, Jianying Hu, Robert Sorrentino Healthcare Analytics Research Group IBM T.J. Watson Research
More informationThe NYSCF Research Institute
Regenerative Medicine Research Update Susan L. Solomon The NYSCF Research Institute New York Pharma Forum February 25, 2016 Regenerative Medicine Research Regenerative medicine uses laboratory grown human
More information- OMICS IN PERSONALISED MEDICINE
SUMMARY REPORT - OMICS IN PERSONALISED MEDICINE Workshop to explore the role of -omics in the development of personalised medicine European Commission, DG Research - Brussels, 29-30 April 2010 Page 2 Summary
More informationTruSeq Nano DNA Sample Preparation Guide FOR RESEARCH USE ONLY
TruSeq Nano DNA Sample Preparation Guide FOR RESEARCH USE ONLY ILLUMINA PROPRIETARY Catalog # FC-121-9010DOC Part # 15041110 Rev. A May 2013 This document and its contents are proprietary to Illumina,
More informationAccessible answers. Targeted sequencing: accelerating and amplifying answers for oncology research
Accessible answers Targeted sequencing: accelerating and amplifying answers for oncology research Help advance precision medicine Accelerate results with Ion Torrent NGS Life without cancer. This is our
More informationGlobal Screening Array (GSA)
Technical overview - Infinium Global Screening Array (GSA) with optional Multi-disease drop in (MD) The Infinium Global Screening Array (GSA) combines a highly optimized, universal genome-wide backbone,
More informationYour genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health
Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, 2018 Franziska Moeckel AVP, Personalized Health Your genes. Your roadmap. Overview Inova s Precision Medicine Journey MediMap
More information15.3 Applications of Genetic Engineering
15.3 Applications of Genetic Engineering Agriculture and Industry Almost everything we eat and much of what we wear come from living organisms. Researchers have used genetic engineering to try to improve
More informationNanthealth Patient Informed Consent
Patient Informed Consent Why am I being asked to give consent? You are being asked to sign this consent form because you want to have a molecular/genomic analysis performed to help your physician understand
More informationPreparing Samples for Multiplexed Paired-End Sequencing
Preparing Samples for Multiplexed Paired-End Sequencing FOR RESEARCH ONLY Topics 3 Introduction 4 Sample Preparation Workflow 5 Kit Contents and User-Supplied Consumables 8 Fragment the DNA 12 Perform
More informationInformatic Issues in Genomics
Informatic Issues in Genomics DEISE PRACE Symposium Barcelona, 10 12 May 2010 Ivo Glynne Gut, PhD Centro Nacional de Analisis Genomico Barcelona Our Objectives Improve the quality of life Understand the
More informationExome Sequencing Exome sequencing is a technique that is used to examine all of the protein-coding regions of the genome.
Glossary of Terms Genetics is a term that refers to the study of genes and their role in inheritance the way certain traits are passed down from one generation to another. Genomics is the study of all
More informationYour story is unique. Diet & Exercise. Environment. Your health. Lifestyle. Genetics A PICTURE OF YOUR HEALTH
What s your story? Your story is unique It s a complex intersection of where you ve come from, and where your everyday choices are taking you. Optimal health choices for you might be different from others.
More informationNotice. Part # Rev. B
Notice This document and its contents are proprietary to Illumina, Inc. and its affiliates ("Illumina"), and are intended solely for the contractual use of its customer in connection with the use of the
More informationMedical Devices for The Non-Communicable Diseases Agenda Nicole Denjoy
Medical Devices for The Non-Communicable Diseases Agenda Nicole Denjoy DITTA Chair COCIR Secretary General 2 nd WHO Global Forum on Medical Devices Geneva, Switzerland Plenary session 3 on Sunday 24 November
More informationTransform Clinical Research Into Value-Based Personalized Care
SAP Brief PUBLIC SAP Medical Research Insights Transform Clinical Research Into Value-Based Personalized Care SAP Brief Seamlessly combine clinical research with clinical routine Cutting-edge clinical
More informationMolecular Diagnostics: Market Segmentation and Opportunities
Molecular Diagnostics: Market Segmentation and Opportunities October 2010 This market report is published by DeciBio, LLC. All rights reserved. Reproduction or redistribution of this report in any form
More information2019 JP Morgan Healthcare Conference
2019 JP Morgan Healthcare Conference Francis desouza President & CEO January 7, 2019 2019 Illumina, Inc. All rights reserved. Safe Harbor Statement This communication may contain statements that are forward-looking.
More informationTruSeq Custom Amplicon v1.5 Protocol Guide
TruSeq Custom Amplicon v1.5 Protocol Guide For Research Use Only. Not for use in diagnostic procedures. Hybridize Oligo Pool 3 Remove Unbound Oligos 4 Extend and Ligate Bound Oligos 5 Amplify Libraries
More informationComputational Challenges of Medical Genomics
Talk at the VSC User Workshop Neusiedl am See, 27 February 2012 [cbock@cemm.oeaw.ac.at] http://medical-epigenomics.org (lab) http://www.cemm.oeaw.ac.at (institute) Introducing myself to Vienna s scientific
More informationAccelerating Precision Medicine with High Performance Computing Clusters
Accelerating Precision Medicine with High Performance Computing Clusters Scalable, Standards-Based Technology Fuels a Big Data Turning Point in Genome Sequencing Executive Summary Healthcare is in worldwide
More informationThe NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England
The NHS approach to personalised medicine in respiratory disease Professor Sue Hill @CSOSue Chief Scientific Officer for England Jul 2017 Genomics is probably the biggest breakthrough in the last 50 years.
More informationMutations : D: a permanent change made to one section of DNA
Mutations : distinguish between somatic and germ mutations explain the different types of mutations explain how jumping genes influence diversity identify diseases caused by chromosomal mutations (Downs,
More informationSmall RNA Sample Preparation Guide
Small RNA Sample Preparation Guide FOR RESEARCH USE ONLY Introduction 3 Sample Prep Workflow 4 Best Practices 5 RNA Input Recommendations 6 Kit Contents 7 Consumables and Equipment 10 Isolate Small RNA
More informationTruSeq Sample Preparation Best Practices and Troubleshooting Guide
TruSeq Sample Preparation Best Practices and Troubleshooting Guide FOR RESEARCH USE ONLY Introduction 3 Liquid Handling 4 RNA Handling 5 Master Mix Reagent Handling 6 AMPure XP Handling 7 Avoid Cross-Contamination
More informationVeraCode ADME Core Panel Assay Guide FOR RESEARCH USE ONLY
VeraCode ADME Core Panel Assay Guide FOR RESEARCH USE ONLY ILLUMINA PROPRIETARY Catalog # VC-801-1002 Part # 15007510 Rev. C June 2011 ii Part # 15007510 Rev. C Notice This document and its contents are
More informationTargeted Sequencing in the NBS Laboratory
Targeted Sequencing in the NBS Laboratory Christopher Greene, PhD Newborn Screening and Molecular Biology Branch Division of Laboratory Sciences Gene Sequencing in Public Health Newborn Screening February
More information